Clinical significance of tumor content of epidermal growth factor receptor in breast cancer;Significación clínica del contenido tumoral del receptor del factor de crecimiento epidérmico en el cáncer de mama

Revista Espanola de Medicina Nuclear

Volumn 22, Issue 6, 2003, Pages 386-394

  Mulero, M ^a   Fernandez Raigoso P ^b   Vazquez J ^c   Lamelas, Ma L ^a   Corte, D ^c   Allende, M T ^b   Rodriguez J C ^c   Vizoso, F ^c  

^a Medicina de Familia y Comunitaria   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^c HOSPITAL DE JOVE   (Spain)

Author keywords

Breast cancer; Epidermal growth factor receptor (EGFR)

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TUMOR MARKER; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER TISSUE; CORRELATION ANALYSIS; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PARAMETER; PROGNOSIS; RADIOASSAY; BREAST TUMOR; CANCER INVASION; CARCINOMA; CHEMISTRY; LIFE TABLE; MIDDLE AGED; MORTALITY; PATHOLOGY; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA; FEMALE; HUMANS; LIFE TABLES; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROGNOSIS; RADIOLIGAND ASSAY; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 1542708688     PISSN: 02126982     EISSN: 1578200X     Source Type: Journal    
DOI: 10.1157/13052912     Document Type: Article

References (38)

1. Olayioye MA, Neve RM, Lane HA, Hynes NE. The ErbB signalling network: Receptor heterodimerization in development and cancer. EMBO J 2000;19:3159-67.
2. Salomon DS, Brandt R, Ciardiello F, Normanno N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 1995;19:183-232.
3. De Jong JS, van Diest PJ, van der Valk P, Baak JP. Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer.II: Correlations with proliferation and angiogenesis. J Pathol 1998;184:53-7.
4. Radinsky R, Risin S, Fan Z, Dong, Bielenberq, Bucana, et al. Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells. Clin Cancer Res 1995;1:19-31.
5. Woodburn JR, Morris CQ, Kelly H, Laight A. EGF receptor tyrosine Kinase inhibitors as anti-cancer agents - preclinical and early clinical prolife of ZD1839. Cell and Mol Biol Lett 1998;3: 348-9.
6. Ciardiello F, Caputo R, Bianco R, Damiano V, Fontanini G, Cuccato S, et al. Inhibition of growth factor production and angiogenesis in hunan cancer cells by ZD1839 ('Iressa'), a selective epidermal growth factor receptor tyrosine Kinase inhibitor. Clin Cancer Res 2001;149-65.
7. Woodburn JR. The epidermal growth factor receptor and its inhibition in cancer therapy. Pharmacol Ther 1999; 82: 241-250.
8. Huang SM, Harari PM. Epidermal growth factor receptor inhibition in cancer therapy: Biology, rationale and preliminary clinical results. Invest New Drugs 1999;17:259-69.
9. Brandt BH, Roetger A, Dittmar T, Nikolai G, Seeling M, Merschjann A, et al. c-erb-2/EGFR as dominant heterodimerization partners determine a motogenic phenotype in human breast cancer cells. FASEB, 1999.
10. Klijn JGM, Berns PMJJ, Schmitz PIM, Foekens JA. The clinical significance of epidermal growth factor receptor in human breast cancer: A review on 5232 patients. Endocrine Rev 1992;13:3-17.
11. Delarue JC, Friedman S, Mouriesse H, May Levin F, Sancho Garnier H, Contesso G. Epidermal growth factor receptor in human breast cancers: correlation with estrogen and progesterone receptors. Breast Cancer Res Treat 1988 11: 173-178.
12. Harris AL, Nicholson S, Sainsbury JRC, Farndon J, Wright C. Epidermal growth factor receptors in breast cancer: Association with early relapse and death, poor response to hormones and interactions with neu. J Steroid.Biochem 1989;34:123-31.
13. Fox SB, Smith K, Hollyer J, Greenal M, Hastrich D, Harris Al. The epidermal growth factor receptor as a prognostic marker: Results of 370 patients and review of 3009 patients. Breast Cancer Res Treat 1994;29:41-9.
14. Ferrero JM, Ramaioli A, Largillier J, Formento JL, Francoual M, Ettore F, et al. Epidermal growth factor receptor expression in 780 breast cancer patients: A reappraisal of the prognostic value based on an eight-year median follow-up. Ann of Oncol 2001; 12:841-6.
15. Tsutsui S, Ohno S, Murakami S, Hachitanda Y, Oda S. Prognosis value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer. Breast Cancer Res and Treat 2002;71:67-75.
16. Fitzpatrick SL, LaChance MP, Shultz GS. Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture. Cancer Res 1984; 44: 3442-3447.
17. Mori T, Morimoto T, Komaki K, Monden Y. Comparison of estrogen receptor and epidermal growth factor receptor content of primary and involved nodes in human breast cancer. Cancer 1991;68:532-7.
18. Gasparini G, Boracchi P, Bevilacqua P, Mezzetti M, Pozza F, Weidner N. A multiparametric study on the prognostic value of epidermal growth factor receptor in operable breast carcinnoma. Breast Cancer Res Treat 1994;29:59-71.
19. Pirinen R, Lipponen P, Syrjanen K. Expression of epidermal growth factor receptor (EGFR) in brast cancer as related to clinical, prognostic and cytometric factors. Anticancer Res 1995;15: 2835-40.
20. Neskovic-Konstantinovic Z, Nikolic-Vukosavljevic D, Brankovic-Magic M, Kanjer J, Gavrilovic D, Mitrovic L. Expression of epidermal growth factor receptor in breast cancer, from early stages to advanced disease. J. Exp. Clin. Cancer Res 1999;18:347-55.
21. Costa S, Stamm H, Almendral A, Ludwig H, Wyss R, Fabbro D, et al. Predictive value of EGF receptor in breast cancer. Lancet 1988;2:1258.
22. Foekens JA, Portengen H, van Putten WLJ, Trapman AMAC, Reubi JC, Alexieva-Figusch J, et al. Prognostic value of receptors for insulin-like growth factor 1, somatostatin, and epidermal growth factor in human breast cancer. Cancer Res 1989;49:7002-9.
23. Klijn JGM, Look MP, Portengen H, Alexieva-Figusch J, Van Putten WLJ, Foekens JA. The prognostic value of epidermal growth factor receptor (EGF-R) in primary breast cancer: Results of a 10 year follow-up study. Breast Cancer Res Treat 1994; 29:73-83.
24. Nicholson S, Sainsbury C, Halcrow P, Chambers P, Farndon JR, Harris AL. Expression of epidermal growth factor receptors associated with lack of response to endocrine therapy in recurrent breast cancer. Lancet 1989;1:182-4.
25. Neskovic-Konstantinovic ZB, Nikolic-Vukosavljevic DB, Brankovic-Magic MV, Mitrovic LB, Spuzic I. Content of epidermal growth factor receptor in metastatic breast cancer: Its role in endocrine sensitivity prediction.Neoplasma 2000;47:2.
26. Bradford M. A rapid and sensitive method for the quantification off microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
27. Darcy KM, Wohlhueter AL, Zangani D, Vaughan MM, Russell JA, Masso-Welch PA, et al. Selective changes in EGF receptor expression and function during the proliferation, differentiation and apoptosis of mammary epithelial cells. Eur J Cell Biol 1999;511-23.
28. Gompel A, Martin A, Simon P, Schoevaert D, Plu-Bureau G, Hugol D, et al. Epidermal growth factor receptor and c-erbB-2 expression in normal breast tissue during the menstrual cycle. Breast Cancer Res Treat 38:227-35.
29. Allende MT, Raigoso PF, Alvarez A, Llana B, Sanchez A, Martinez MI, et al. Valoration of epidermal growth factor receptor (EGFR) in benign breast disease and its relation with expression in malignant tumors classified by hormonal dependence. Rev Esp Med Nucl 1999;18:32-6.
30. Niewiadomska H, Mirowski M, Stempien M, Blonski JZ, Czyz W, Switalska J, et al. Immunohistochemical analysis of expression of a 65 Kda oncofetal protein (p65), epidermal growth factor receptor (EGFR), oncogene c-erbB-2 and tumor suppressor gene p53 protein products in breast cancer patients. Neoplasma 2000;47:8-14.
31. Bevilacqua P, Gasparini G, Dal Fior S, Corradi G.:Inmunocytochemical determination of epidermal growth factor receptor with monoclonal EGFR1 antibody in primary breast cancer patients. Oncology, 1990;47:313-7.
32. Soares R, Pereira MB, Silva C, Amendoeira I, Wagner R, Ferro J, et al. Expression of TGF-alpha and EGFR in Breast Cancer and its Relation to Angiogenesis. Breast J 2000;6:171-7.
33. Di Fiore PP, Pierce JH, Fleming TP, H R, Ullrich A, King CR, et al. Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells. Cell 1987;51:1063-1070.
34. Ma L, Gauville C, Berthois Y, Degeorges A, Millot G, Martin PM, et al. Role of epidermal-growth -factor receptor in tumor progression in transformed human mammary epithelial cells. Int J Cancer 1998;78:112-9.
35. Ratnakar N, Sharma BK, Chaturvedi KU, Kaur S, Naik SL, Ray A. Immunohistochemical expression of c-erbB-2 oncoprotein and EGF-R in pre- and postmenopausal breast cancer. APMIS 1998;106:1075-80.
36. deFazio A, Chiew YE, Donoghue C, Lee CS, Sutherland RL. Effect of sodium butyrate on estrogen receptor and epidermal growth factor receptor gene expression in human breast cancer cell lines. J Biol Chem 1992;267:18008-12.
37. Van Agthoven T, Van Agthoven TL, Portengen H, Foekens JA, Dorssers LC. Ectopic expresión of epidermal growth factor receptors induces hormone independence in ZR-75-1 human breast cancer cells. Cancer Res 1992;52:5082-8.
38. Yarden RI, Wilson MA, Chrysogelos SA. Estrogen supression of EGFR expression in breast cancer cells: A possible mechanism to modulate growth. J Cell Biochem 2001;81:232-46.